Protagenic Therapeutics (MBP0) Financial Statements
Protagenic Therapeutics Financial Overview
Protagenic Therapeutics's market cap is currently $1.03M. The company's EPS TTM is $2.95; its P/E ratio is 0.22; Protagenic Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -37.72K | $ -50.29K | $ -28.22K | $ -30.00 | $ 0.00 |
| Operating Income | $ -5.83M | $ -5.70M | $ -4.53M | $ -3.56M | $ -4.14M |
| EBITDA | $ -7.10M | $ -5.47M | $ -4.50M | $ -3.42M | ― |
| Net Income | $ -5.16M | $ -5.53M | $ -5.00M | $ -3.56M | $ -4.52M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.21M | $ 1.84M | $ 4.06M | $ 7.98M | $ 10.37M |
| Total Assets | $ 2.13M | $ 1.96M | $ 4.32M | $ 8.04M | $ 11.06M |
| Total Debt | $ 3.16M | $ 0.00 | $ 0.00 | $ 344.23K | $ 318.43K |
| Net Debt | $ 943.26K | $ -1.84M | $ -1.29M | $ 129.04K | $ -222.74K |
| Total Liabilities | $ 6.82M | $ 942.76K | $ 655.25K | $ 1.12M | $ 1.12M |
| Stockholders' Equity | $ -2.39M | $ 1.01M | $ 3.67M | $ 6.92M | $ 9.94M |
| Cash Flow | |||||
| Free Cash Flow | $ -4.14M | $ -4.22M | $ -3.85M | $ -2.00M | $ -2.80M |
| Operating Cash Flow | $ -4.14M | $ -4.22M | $ -3.70M | $ -1.99M | $ -2.80M |
| Investing Cash Flow | $ 943.18K | $ 2.80M | $ 4.78M | $ 1.60M | $ -9.91M |
| Financing Cash Flow | $ 4.51M | $ 1.96M | $ 0.00 | $ 0.00 | $ 12.58M |
Currency in USD
